Treatment‐related adverse effects · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Degree of penile curvature · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
1 finding from 1 review
Treatment discontinuation · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
It is very uncertain whether injectional interferon alpha‐2B changes discontinuation from treatment compared with saline (very low certainty).
1 finding from 1 review
Outcomes ( · men with chronic Peyronie's disease (plaques without calcification)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported ability to have intercourse · men with chronic Peyronie's disease (plaques without calcification)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · men with chronic Peyronie's disease (plaques without calcification)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects · men with chronic Peyronie's disease (plaques without calcification)
It is very uncertain whether injectional nicardipine changes treatment‐related adverse effects compared with saline (very low certainty).
1 finding from 1 review
Degree of penile curvature · men with chronic Peyronie's disease (plaques without calcification)
1 finding from 1 review
Treatment discontinuation · men with chronic Peyronie's disease (plaques without calcification)
It is very uncertain whether injectional nicardipine changes discontinuation from treatment compared with saline (very low certainty).
1 finding from 1 review
Outcomes ( · men with Peyronie's disease (not defined)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported ability to have intercourse · men with Peyronie's disease (not defined)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · men with Peyronie's disease (not defined)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects (long‐term) · men with Peyronie's disease (not defined)
1 finding from 1 review
Degree of penile curvature · men with Peyronie's disease (not defined)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · men with Peyronie's disease (not defined)
1 finding from 1 review
Outcomes ( · men with Peyronie's disease (palpable plaque or pain)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported ability to have intercourse · men with Peyronie's disease (palpable plaque or pain)
It is very uncertain whether injectional verapamil changes patient‐reported ability to have intercourse compared with saline (short‐term) (very low certainty).
1 finding from 1 review
Quality of life · men with Peyronie's disease (palpable plaque or pain)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects · men with Peyronie's disease (palpable plaque or pain)
1 finding from 1 review
Degree of penile curvature · men with Peyronie's disease (palpable plaque or pain)
1 finding from 1 review